Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

4.3%

1 terminated/withdrawn out of 23 trials

Success Rate

90.9%

+4.3% vs industry average

Late-Stage Pipeline

2 trials in Phase 3/4

Results Transparency

0 of 10 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

13(68.4%)

Phase 4

2(10.5%)

Phase 2

2(10.5%)

Phase 1

2(10.5%)

19Total

N/A(13)

Phase 4(2)

Phase 2(2)

Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials

NCT07851779Phase 4Recruiting

Withdrawal of Heart Failure Treatment Patients With Non-ischemic Cardiomyopathy Who Have Been Super-responders to Cardiac Resynchronization Therapy.

Role: collaborator

NCT07665112Not ApplicableNot Yet Recruiting

Algorithm-Based Timing of Delivery Using the sFlt-1/PlGF Ratio in Early-Onset Severe Preeclampsia. (MAP 2 Study : Management Based on Angiogenic Markers in Preeclampsia 2 Study )

Role: collaborator

NCT06653192Not ApplicableSuspended

EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial)

Role: collaborator

NCT06375967Not ApplicableSuspended

EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)

Role: collaborator

NCT02616874Phase 1Completed

Study to Evaluate the Safety and Effect of HIVconsv Vaccines in Combination With Histone Deacetylase Inhibitor Romidepsin on the Viral Rebound Kinetic After Treatment Interruption in Early Treated HIV-1 Infected Individuals

Role: collaborator

NCT06375954Not ApplicableNot Yet Recruiting

EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial)

Role: collaborator

NCT06375928Not ApplicableNot Yet Recruiting

EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction in Resectable Disease (CARPEDIEM-1 Trial)

Role: collaborator

NCT05345977Not ApplicableCompleted

eMotiph: E-mental Health Solution for Patients With Schizophrenia

Role: collaborator

NCT03624621Not ApplicableCompleted

Integral Remediation for Major Depression ("Rehabilitación Integral Para la Depresión Mayor", RIDEM)

Role: lead

NCT05187949Unknown

Promoting Shared-decision Making in Opportunistic Screening for Prostate Cancer

Role: collaborator

NCT05358457Not ApplicableUnknown

Pilot Study to Evaluate the Effectiveness of Online Familiar Metacognitive Training (MCTf)

Role: collaborator

NCT02328885Phase 1Completed

Prophylactic Infusion of Donor Lymphocytes in Cord Blood Transplantation

Role: collaborator

NCT03426735Not ApplicableCompleted

Study of Iodine Contrast Media Extravasation

Role: lead

NCT04592965Not ApplicableUnknown

Hallucinations in Parkinson's Disease

Role: collaborator

NCT02635945Phase 2Completed

A Study to Assess the Efficacy of a 5-day, 10- mg PBF-680 Oral Administration on Late Asthmatic Responses (LAR) in Mild to Moderate Asthmatic Patients.

Role: collaborator

NCT03432234Unknown

Respiratory Microbiome and COPD Exacerbations (RESMECOPD)

Role: collaborator

NCT01790620Not ApplicableCompleted

Impact of CVVHD With Adsorption Capacity Membranes in Septic Acute Kidney Injury

Role: collaborator

NCT03809897Phase 4Withdrawn

Varenicline for Smoking Cessation in Hospitalized Patients With Psychiatric Disorders

Role: collaborator

NCT01608477Unknown

Building Research Initiative Group: Chronic Illness Management and Adherence in Transplantation